MedTrace Logo

In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention

NCT02919098 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 601

Last updated 2023-02-23

No results posted yet for this study

Summary

The investigators have developed a game-based sexual violence prevention program that uses a bystander intervention approach. This program is called Bystander and was designed for use with high school students in grades 9-12. The goal of this research is to evaluate the efficacy and feasibility of Bystander when implemented in a school setting. The research will capture data on knowledge about sexual violence and harassment, as well as attitudes, self-efficacy, perceived social norms and behavioral intentions around bystander behaviors. This research will consist of a baseline survey, program participation, a immediate post-program survey, and a 3-month follow up survey with youth participants. It will also involve qualitative in-depth interviews with school staff and administration about the program.

Conditions

  • Bystander Behavioral Intentions

Interventions

BEHAVIORAL

Bystander, a game-based bystander intervention program

A game-based, high school age-appropriate program delivered by trained facilitators for sexual violence and harassment intervention

BEHAVIORAL

Infection City, a game-based program about meningitis

A game-based, high school age-appropriate program delivered by trained facilitators to teach students about meningitis.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Melissa Gilliam, MD, MPH · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02919098 on ClinicalTrials.gov